10x Genomics Inc (NASDAQ:TXG) price closed higher on current market day and jumping 5.55% above its previous close.
A look at the daily price movement shows that the last close reads $10.09. Taking into account the 52-week price action we note that the stock hit a 52-week high of $24.76 and 52-week low of $6.78. The stock added 21.44% on its value in the past month.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 8 analysts have assigned TXG a recommendation rating as follows: 5 rate it as a Hold; 3 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the 10x Genomics Inc (TXG) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Hold, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that TXG’s price is at present 15.83% off the SMA20 and 23.70% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 66.58, with weekly volatility standing at 4.11%. The indicator jumps to 4.26% when calculated based on the past 30 days. 10x Genomics Inc (NASDAQ:TXG)’s beta value is holding at 1.98, while the average true range (ATR) indicator is currently reading 0.61. Considering analysts have assigned the stock a price target range of $24-$46 as the low and high respectively, we find the trailing 12-month average consensus price target to be $25. Based on this estimate, we see that current price is roughly -125.35% off the estimated low and -331.92% off the forecast high. Investors will no doubt be excited to see the share price fall to $25, which is the median consensus price, and at that level TXG would be -134.74% from current price.
Current records show that the company has 109.08M in outstanding shares. The insiders’ percentage holdings are 17.19% of outstanding shares while the percentage share held by institutions stands at 90.02%. But the -25.84% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
